Suspended NA INTERVENTIONAL 1-arm NCT04194476

Performance Study of Nova StatStrip® Blood Glucose Monitoring Test System on Neonatal Capillary Blood

Sponsor: Nova Biomedical

Conditions Healthy and Unhealthy Neonates

Interventions StatStrip blood glucose meter and strips

Updated 8 times since 2020 Last updated: Apr 9, 2024 Started: Jan 1, 2025 Primary completion: Mar 30, 2025 Completion: Mar 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

The protocol needs to be further developed.

Listed as NCT04194476, this NA trial focuses on Healthy and Unhealthy Neonates and remains suspended. Sponsored by Nova Biomedical, it has been updated 8 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
May 2024 — Jul 2024 [monthly]

Suspended NA

Status: Not Yet Recruiting → Suspended
Sep 2022 — May 2024 [monthly]

Not Yet Recruiting NA
Jan 2022 — Sep 2022 [monthly]

Not Yet Recruiting NA

▶ Show 3 earlier versions

Jan 2021 — Jan 2022 [monthly]

Not Yet Recruiting NA
Feb 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA
Jan 2020 — Feb 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nova Biomedical

Data source: Nova Biomedical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China